Medical equipment manufacturer Mindray Medical International has made changes to its executive management team.
The firm has tapped current chief strategic officer Cheng Minghe to be co-CEO. He will continue to maintain his role as chief strategic officer.
Meanwhile, Li Xiting, Mindray's president and CEO, will now be president and co-CEO and will remain the company's director of the board.
Cheng will assist Li in executing the company's strategies and overseeing its operations. As a co-founder of Mindray, Cheng has served in various roles across sales, marketing, and strategic development since the company was established in 1991.
In other news, the company appointed Wang Jianxin to be chief administrative officer and May Li to be chief investment officer.
All appointments will take effect immediately.
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)